Mayne Pharma reported AUD-154116000 in Operating Profit for its first fiscal semester of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Ansell ANN:AU USD 122.9M 9.2M
Cochlear COH:AU AUD 165.6M 68.8M
CSL CSL:AU USD 712.7M 1.5B
Ecofibre Ltd EOF:AU AUD -11410000 2.45M
Healius Ltd HLS:AU AUD 105.7M 256M
Integral Diagnostics Ltd IDX:AU AUD 12.94M 7.29M
Medical Developments International Ltd MVP:AU AUD -9450000 4.18M
Nanosonics Ltd NAN:AU AUD -1569000 4.92M
Next Science Ltd NXS:AU USD -6582880 1.37M
Polynovo Ltd PNV:AU AUD -2671410 4.51M
Probiotec Ltd PBP:AU AUD 11.76M 5.48M
Ramsay Health Care RHC:AU AUD 416M 54.4M
ResMed RMD:AU USD 255.4M 21.13M
Sigma Healthcare Ltd SIG:AU AUD 5.4M 7.46M
Sonic Healthcare SHL:AU AUD 948.26M 260.51M
Telix Pharmaceuticals Ltd TLX:AU AUD -67386000 22.08M